Target intelligence / Profile preview

Eukaryotic translation initiation factor 4E pseudogene 4 (EIF4EP4)

Target: EIF4EP4
Molecular classification: Other

Overview

Eukaryotic translation initiation factor 4E pseudogene 4 (EIF4EP4) is classified as a pseudogene, not a protein-coding gene, and thus does not produce an active protein product. The official pseudogene is related to the eukaryotic translation initiation factor 4E (EIF4E), which plays a pivotal role in the cap-dependent initiation of translation and is well-studied in the context of cell growth and cancer[1][2][3]. Unlike EIF4E, there is no evidence supporting biological function, therapeutic relevance, disease association, drug interactions, or use as a biomarker for EIF4EP4. The entry likely refers to a non-functional pseudogene and not a valid therapeutic target.

Other names: EIF4EP4

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4E pseudogene 4 (EIF4EP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4E pseudogene 4 (EIF4EP4).

Explore the full profile